Zobrazeno 1 - 10
of 74
pro vyhledávání: ''
Autor:
Joan K. Moore, Ann Setser, Kevin L. Stephans, Lawrence Berk, Tito R. Mendoza, Amylou C. Dueck, Deborah Watkins Bruner, Sandra A. Mitchell, Ann M. O'Mara, Shannon Fogh, Albert S. DeNittis, Lori M. Minasian, Lauren J. Rogak, Stephanie L. Pugh, Andreas Rimner, Antonia V. Bennett, Thomas Gergel, Bryce B. Reeve, Ethan Basch, Andrea Denicoff, Kevin S. Roof, Marcha L. Gatewood, Deborah Schrag
Purpose To assess the feasibility of measuring symptomatic adverse events (AEs) in a multicenter clinical trial using the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad2959c9092ddc87b88cf644f9917604
Autor:
Meng Fen Wu, Tara Gray, John Hicks, Oumar Diouf, Zhongzhen Yi, Stephen Gottschalk, Meenakshi Hegde, Catherine Robertson, Vita S. Brawley, Claudia Gerken, Amanda Wakefield, Helen E. Heslop, Pamela New, Hao Liu, Mamta Kalra, Yvonne Kew, Winfried S. Wels, Robert G. Grossman, Milica Stojakovic, Alexia Ghazi, Kevin Bielamowicz, Aidin Ashoori, David S. Baskin, Cliona M. Rooney, Gianpietro Dotti, Yi Jonathan Zhang, Suzanne Zein-Eldin Powell, Nabil Ahmed, Adrian P. Gee, Bambi Grilley, Malcolm K. Brenner, Jack Su, Daniel Landi
Glioblastoma is an incurable tumor, and the therapeutic options for patients are limited. To determine whether the systemic administration of HER2-specific chimeric antigen receptor (CAR)-modified virus-specific T cells (VSTs) is safe and whether the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d7c2c0e930a946260a767da89b32c40
Autor:
Chih Jian Lih, Simon Rule, Pier Luigi Zinzani, Jacqueline Russo, Patrick Hagner, Marek Trněný, Gilles Salles, Randy D. Gascoyne, Graham W. Slack, Myron S. Czuczman, Kim Linton, Andrew Davies, Louis M. Staudt, David A. Eberhard, Yandan Yang, Thomas E. Witzig, George E. Wright, Pierre Brousset, Dale Song, Ian D. Lewis, Francisco J. Hernandez-Ilizaliturri, Anjan Thakurta, Pierre Fustier, Nina D. Wagner-Johnston, P. Mickey Williams
Publikováno v:
Clin Cancer Res
Purpose: Randomized, multicenter, open-label, phase 2/3 trial investigating lenalidomide versus investigator's choice (IC) in relapsed/refractory diffuse large B-cell lymphoma (DLBCL). Experimental Design: Patients with DLBCL who received ≥2 prior
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a09e2e36577b2a5d62029814a6b2b2d
Autor:
Lazar, AJ, McLellan, MD, Bailey, MH, Miller, CA, Appelbaum, EL, Cordes, MG, Fronick, CC, Fulton, LA, Fulton, RS, Mardis, ER, Schmidt, HK, Wong, W, Wilson, RK, Yellapantula, V, Radenbaugh, AJ, Hoadley, KA, Hayes, DN, Parker, JS, Wilkerson, MD, Auman, JT, Balu, S, Bodenheimer, T, Hoyle, AP, Jefferys, SR, Jones, CD, Lehmann, K-V, Meng, S, Mieczkowski, PA, Mose, LE, Perou, CM, Roach, J, Senbabaoglu, Y, Shi, Y, Simons, JV, Skelly, T, Soloway, MG, Tan, D, Veluvolu, U, Davis, IJ, Hepperla, AJ, Brohl, AS, Kasaian, K, Mungall, K, Sadeghi, S, Barthel, FP, Verhaak, R, Hu, X, Chibon, F, Cherniack, AD, Shih, J, Beroukhim, R, Meyerson, M, Cibulskis, C, Gabriel, SB, Saksena, G, Schumacher, SE, Gao, Q, Wyczalkowski, M, Bowlby, R, Robertson, AG, Ally, A, Balasundaram, M, Brooks, D, Carlsen, R, Chuah, E, Dhalla, N, Holt, RA, Jones, SJM, Lee, D, Li, I, Ma, Y, Marra, MA, Mayo, M, Moore, RA, Mungall, AJ, Schein, JE, Sipahimalani, P, Tam, A, Thiessen, N, Wong, T, Danilova, L, Cope, L, Baylin, SB, Bootwalla, MS, Lai, PH, Laird, PW, Maglinte, DT, Van Den Berg, DJ, Weisenberger, DJ, Wrangle, J, Drill, E, Shen, R, Iype, L, Reynolds, SM, Shmulevich, I, Yau, C, Armenia, J, Liu, EM, Benz, C, Pastore, A, Sanchez-Vega, F, Schultz, N, Akbani, R, Hegde, AM, Liu, W, Lu, Y, Mills, GB, Weinstein, JN, Roszik, J, Anur, P, Spellman, P, Abeshouse, A, Chen, H-W, Gao, J, Heins, Z, Kundra, R, Larsson, E, Ochoa, A, Sander, C, Socci, N, Zhang, H, Noble, MS, Heiman, DI, Kim, J, Chin, L, Getz, G, Cho, J, Defreitas, T, Frazer, S, Gehlenborg, N, Lawrence, MS, Lin, P, Meier, S, Voet, D, Byers, L, Diao, L, Gay, CM, Wang, J, Newton, Y, Cooper, LAD, Gutman, DA, Lee, S, Nalisnik, M, Bowen, J, Gastier-Foster, JM, Gerken, M, Helsel, C, Hobensack, S, Leraas, KM, Lichtenberg, TM, Ramirez, NC, Wise, L, Zmuda, E, Anderson, ML, Castro, P, Ittmann, M, Gordienko, E, Paklina, O, Setdikova, G, Raut, CP, Karlan, BY, Lester, J, Belyaev, D, Fulidou, V, Potapova, O, Voronina, O, Demetri, GD, Ramalingam, SS, Behera, M, Delman, K, Owonikoko, TK, Sica, GL, Boyd, J, Magliocco, A, Salner, A, Bennett, J, Iacocca, M, Swanson, P, Dottino, P, Kalir, T, Pereira, E, Akeredolu, T, Crain, D, Curley, E, Gardner, J, Mallery, D, Morris, S, Paulauskis, J, Penny, R, Shelton, C, Shelton, T, Thompson, E, Hoon, DB, Parfitt, J, Birrer, M, Karseladze, A, Mariamidze, A, Dao, F, Levine, DA, Olvera, N, Maki, RG, Bartlett, J, Eschbacher, J, Dubina, M, Mozgovoy, E, Fedosenko, K, Manikhas, G, Sekhon, H, Ramirez, N, Ingram, DR, Torres, KE, DiSaia, P, Godwin, AK, Godwin, EM, Kuo, H, Madan, R, Reilly, C, Adebamowo, C, Adebamowo, SN, Bocklage, T, Higgins, K, Martinez, C, Boice, L, Grilley-Olson, JE, Huang, M, Perou, AH, Thorne, LB, Rathmell, WK, Gutmann, DH, Singer, S, Chudamani, S, Liu, J, Lolla, L, Naresh, R, Pihl, T, Sun, Q, Wan, Y, Wu, Y, Felau, I, Zenklusen, JC, Demchok, JA, Ferguson, ML, Hutter, CM, Sofia, HJ, Tarnuzzer, R, Wang, Z, Yang, L, Zhang, JJ, Demicco, EG, Doyle, LA, Hornick, JL, Rubin, BP, de Rijn, MV, Baker, L, Riedel, RF, Ding, L, Ladanyi, M, Novak, JE, Van Tine, BA, Davis, LE, Grilley-Olsen, JE, Pollock, RE, Jones, KB, Martignetti, JA, Tong, P, Network, CGAR
Publikováno v:
Lazar, AJ; McLellan, MD; Bailey, MH; Miller, CA; Appelbaum, EL; Cordes, MG; et al.(2017). Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. CELL, 171(4), 950-+. doi: 10.1016/j.cell.2017.10.014. UCLA: Retrieved from: http://www.escholarship.org/uc/item/47j3z4n7
Summary Sarcomas are a broad family of mesenchymal malignancies exhibiting remarkable histologic diversity. We describe the multi-platform molecular landscape of 206 adult soft tissue sarcomas representing 6 major types. Along with novel insights int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c86ec3399a3a9a3d27362677c3acb09
Autor:
Karteek Popuri, Hyman B. Muss, Shlomit S. Shachar, Kirsten A. Nyrop, Grant R. Williams, Seul Ki Choi, Allison M. Deal, Marc S. Weinberg
Purpose: Poor body composition metrics (BCM) are associated with inferior cancer outcomes; however, in early breast cancer (EBC), there is a paucity of evidence regarding the impact of BCM on toxicities. This study investigates associations between B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dde4699125790a22b0eb2bf8ca16ba3a
Autor:
Antoinette M. Stroup, Ruofei Du, Jeanne S. Mandelblatt, Anita Y. Kinney, Marc Schwartz, Ji-Hyun Lee, Kristina G. Flores, Laurie E. Steffen, Barbara H. Brumbach, Saundra S. Buys, Karin M. Butler, Rebecca A. Campo, Amanda Gammon, Wendy Kohlmann
Purpose The ongoing integration of cancer genomic testing into routine clinical care has led to increased demand for cancer genetic services. To meet this demand, there is an urgent need to enhance the accessibility and reach of such services, while
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40a3d4f54410705bc775364a1a11df89
Autor:
Pamela Jo Harris, S. Percy Ivy, Joshua F. Zeidner, Matthew C. Foster, Gary L. Smith, Judith E. Karp, E. Claire Dees, Amanda L. Blackford
BACKGROUND Therapy for acute myeloid leukemia (AML) has largely remained unchanged, and outcomes are unsatisfactory. We sought to analyze outcomes of AML patients enrolled in phase I studies to determine whether overall response rates (ORR) and morta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35a2b1152954416c9f5532fe879ae676
Autor:
Alfred I. Neugut, Nikhil K. Khankari, Marilie D. Gammon, Mary S. Wolff, Humberto Parada, Lawrence S. Engel, Susan L. Teitelbaum, Sybil M. Eng
Polychlorinated biphenyls (PCBs) are hypothesised to influence breast carcinogenesis due to their persistence and potential to induce oestrogenic and anti-oestrogenic effects. Whether PCBs influence survival following breast cancer is unknown.A popul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69ae0f5b5e73e5bc3627e12a2762993c
Autor:
Eboneé N. Butler, Chiu Kit Tse, Melissa A. Troester, Kathleen Conway, Mary Elizabeth Bell, Andrew F. Olshan
Growing evidence suggests an association between active cigarette smoking and increased breast cancer risk. However, the weak magnitude of association and conflicting results have yielded uncertainty and it is unknown whether associations differ by b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3aa061fd669eb7c603bd39a9ad04f49
Autor:
Federico Innocenti, Lisa A. Carey, William T. Barry, Arti Hurria, Mary Ellen Moynahan, Debasish Tripathy, Diana Lake, Olwen Hahn, Bryan P. Schneider, Clifford A. Hudis, Constance Cirrincione, Hope S. Rugo, Eric P. Winer, Maura N. Dickler, Matthew J. Ellis
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 34, iss 22
Purpose To investigate whether anti–vascular endothelial growth factor therapy with bevacizumab prolongs progression-free survival (PFS) when added to first-line letrozole as treatment of hormone receptor–positive metastatic breast cancer (MBC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44900cf575ef52569d0a48537eb7b5f5